my understanding is this is a typical case of the generics having a crack - Acrux has the patients and so the risk of them being struck out by the courts is low...
Ann: Acrux generic strategy and Axiron patent litigation update-ACR.AX, page-6
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 141351 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 73455 | 1 |
View Market Depth
| Last trade - 10.45am 10/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable